Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms by Site × tucatinib × CNS × Clear all

Status

No longer available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 6 Breast Neoplasms 4 Neoplasms by Site 1 Neoplasms 1 Meningeal Neoplasms 1 Meningeal Carcinomatosis 1 Central Nervous System Diseases 1 Breast Diseases 1

Interventions

selpercatinib 2 tucatinib 1 trametinib 1 pamiparib 1 glutathione pegylated liposomal doxorubicin 1 elacestrant 1 dabrafenib 1 cobimetinib 1 alectinib 1 abemaciclib 1 Vemurafenib 1 Trastuzumab 1 Radiation 1 RAD1901 1 Pemetrexed 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03424473 2020-02-25

Expanded Access Use of Tucatinib for HER2+ Metastatic Breast Cancer

Seagen Inc.

No longer available

Brain Neoplasms, Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site

Data powered by HemOnc (CC BY 4.0) Colophon ⚡